All Topics
All Topics
Technology
Technology
Design
Design
Programming
Programming
Science
Science
News
News
Gaming
Gaming
Entertainment
Entertainment
Business
Business
Finance
Finance
Sports
Sports
Health
Health
Food
Food
Travel
Travel
Art
Art
Music
Music
Books
Books
Education
Education
Politics
Politics
Personal
Personal
No algorithm. No AI slop. No ads. Just RSS. Pro-human. Indie writers. Real journalism. Open web. Chronological. Hand toasted.

Stanford Researchers Develop Universal Vaccine Formula Protecting Mice Against Respiratory Viruses, Bacteria, and Allergens

By

phony-account

2mo ago· 29 min readenNews

Summary

Stanford Medicine researchers have developed a universal vaccine formula that protects mice against a wide range of respiratory viruses, bacteria, and allergens. The intranasal vaccine represents a significant step toward a universal vaccine that could provide broad protection against multiple respiratory pathogens and allergens in a single formulation.

Key quotes

· 5 pulled
In the realm of medical advancements, a universal vaccine that can protect against any pathogen has long been a Holy Grail — and about as elusive as a mythological vessel.
Stanford Medicine researchers and collaborators have taken an astonishing step forward in that quest, surprising even themselves.
In a new study in mice, they have developed a universal vaccine formula that protects against a wide range of respiratory viruses, bacteria and even allergens.
The vaccine is delivered intranasally — such as through a nasal spray — and provides broad protection in the
Stanford Medicine researchers and their colleagues invented a new vaccine that protects mice from respiratory viruses, bacteria and allergens — the closest yet to a universal vaccine.
Snippet from the RSS feed
Stanford Medicine researchers and their colleagues invented a new vaccine that protects mice from respiratory viruses, bacteria and allergens — the closest yet to a universal vaccine.

You might also wanna read

Columbia Researcher Discovers Rare Genetic Mutation That Provides Universal Antiviral Immunity

Columbia University immunologist Dusan Bogunovic discovered that a rare genetic mutation causing immune deficiency in some patients also gra

cuimc.columbia.edu·9mo ago

Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds

Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a

npr.org·3h ago

Spinach-derived photosynthetic treatment shows promise for dry eye disease

Scientists at the National University of Singapore have developed an experimental treatment for dry eye disease that uses photosynthetic mac

biotechniques.com·4h ago

Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1

Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus

biozentrum.unibas.ch·6h ago

Exploring the science behind quantum effects in healthcare: separating research from pseudoscience

The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg

newscientist.com·10h ago

Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial

A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug

chicagotribune.com·11h ago